SCHEMBL6162060

SCHEMBL6162060

CCOc1ccc(CNC(=O)c2c[nH]c3c(c2=O)CCC3)cc1

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.54
TP53 P04637 4/20 0.51
MAPT P10636 2/20 0.47
EPHX2 P34913 1/20 0.46
NR1H4 Q96RI1 1/20 0.46
ADORA2A P29274 1/20 0.45
ADORA1 P30542 1/20 0.45
LMNA P02545 3/20 0.44
KDM4E B2RXH2 1/20 0.44
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
KLKB1 P03952 1/20 0.42
KLK1 P06870 1/20 0.42
XDH P47989 1/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6161126 0.99 POLB (0.55) POLBTP53MAPTEPHX2NR1H4
SCHEMBL6162143 0.89 ADORA2A (0.57) POLBMAPTADORA2AADORA1KMT2A
SCHEMBL6164599 0.88 ADORA2A (0.58) POLBMAPTADORA2AADORA1KMT2A
SCHEMBL6162159 0.87 ADORA2A (0.57) POLBTP53MAPTADORA2AADORA1
SCHEMBL6161991 0.84 ADORA2A (0.57) POLBTP53MAPTADORA2AADORA1
SCHEMBL6161505 0.84 POLB (0.47) POLBTP53MAPTLMNAKDM4E
SCHEMBL6163159 0.84 POLB (0.47) POLBTP53MAPTLMNAKDM4E
SCHEMBL6162507 0.83 ADORA2A (0.55) POLBADORA2AADORA1LMNAKMT2A
SCHEMBL6160996 0.83 ADORA2A (0.55) POLBADORA2AADORA1KMT2AHPGD
SCHEMBL6162124 0.83 ADORA2A (0.45) TP53MAPTADORA2AADORA1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1056724-B1 SUBSTITUTED CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2005-05-25 EP claimed
US-6448259-B1 CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; AGONISTS, ANTAGONISTS OR INVERSE AGONISTS FOR GAMMA AMINOBUTYRIC ACID BINDING SITE, THE BENZODIAZEPINE RECEPTOR; ANXIETY, SLEEP AND SEIZURE DISORDERS SEDATIVE, ANXIOLYTIC AND ANTICONVULSANT ACTIVITY NEUROGEN CORPORATION 2002-09-10 US claimed
EP-1056724-B1 SUBSTITUTED CYCLOALKYL-4-OXONICOTINIC CARBOXAMIDES; GABA BRAIN RECEPTOR LIGANDS NEUROGEN CORP (US) 2005-05-25 EP disclosed